Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > APRE Aprea Therapeutics > Detailed Quotes

APRE Aprea Therapeutics

Watchlist
0.515
+0.035+7.29%
Close  12/05 16:00 ET
0.514
-0.001-0.12%
Post Mkt Price 12/05 16:49 ET
High
0.545
Open
0.504
Turnover
114.91K
Low
0.504
Pre Close
0.480
Volume
220.63K
Market Cap
27.27M
P/E(TTM)
Loss
52wk High
4.110
Shares
53.00M
P/E(Static)
Loss
52wk Low
0.331
Float Cap
20.73M
Bid/Ask %
-33.33%
Historical High
53.110
Shs Float
40.28M
Volume Ratio
3.34
Historical Low
0.331
Dividend TTM
--
Div Yield TTM
--
P/B
1.03
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.55%
Amplitude
8.54%
Avg Price
0.520
Lot Size
1
Float Cap
20.73M
Bid/Ask %
-33.33%
Historical High
53.110
Shs Float
40.28M
Volume Ratio
3.34
Historical Low
0.331
Dividend TTM
--
P/B
1.03
Dividend LFY
--
Turnover Ratio
0.55%
Amplitude
8.54%
Avg Price
0.520
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wen Jie Bao in 2002 and is headquartered in Boston, MA.
CEO: Dr. Oren Gilad, PhD
Market: NASDAQ
Listing Date: 10/03/2019
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist